EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access

Pre-diagnostic circulating bile acid concentrations and liver cancer risk: a nested case-control analysis of 12 cohorts

Cody Z Watling, Jessica L Petrick iD, Barry I Graubard iD, Xuehong Zhang iD, Matthew J Barnett iD, Julie E Buring iD, Yu Chen iD, A Heather Eliassen iD, J Michael Gaziano iD, Jonathan N Hofmann iD, Wen-Yi Huang iD, Jae H Kang iD und 24 weitere

JNCI Cancer Spectrum · 01.09.2025 · 9 (5)

DOI: 10.1093/jncics/pkaf086 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 16.09.2025. Verfasst von Cody Z Watling und 35 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States. Hauptthemen laut MEDLINE: Bile Acids and Salts, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: PHS HHS, NHLBI NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bile acids are produced in the liver and are important for lipid digestion. Higher-circulating bile acid levels, however, have been linked to metabolic disorders, inflammation, and gut microbiota dysbiosis, which have been implicated in liver carcinogenesis. To date, few epidemiological studies have explored the association between circulating bile acids and liver cancer risk.

Methods

We conducted a nested case-control study among 12 prospective cohort studies located in the United States. Fifteen prediagnostic circulating bile acids were measured from blood samples among 872 individuals who developed liver cancer and 872 matched control participants. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using multivariable-adjusted conditional logistic regression analysis of circulating bile acid levels and liver cancer risk.

Results

Primary conjugated bile acid concentrations were positively associated with higher risk of liver cancer (OR per doubling in concentrations [log2] and 95% CI of glycocholic acid: 1.32, 1.24 to 1.40; glycochenodeoxycholic acid: 1.33, 1.24 to 1.43; taurocholic acid: 1.28, 1.22 to 1.35; and taurchenodeoxycholic acid: 1.32, 1.24 to 1.39). Secondary conjugated bile acids were also positively associated with liver cancer risk (doubling of concentrations OR ranged from 1.11 to 1.22). Unconjugated bile acid concentrations were generally not associated with liver cancer risk, except lithocholic acid (OR per doubling: 1.27, 1.16 to 1.39). When analyses were separated into the 2 main subtypes of liver cancer, hepatocellular carcinoma (HCC; 438 cases/438 controls) and intrahepatic cholangiocarcinoma (ICC; 111 cases/111 controls), significant heterogeneity was observed for primary conjugated bile acid concentrations (all P < .001) that showed positive significant associations with HCC but not ICC.

Conclusions

These results suggest that bile acids may be important markers of HCC risk and contribute to hepatocarcinogenesis; however, further research using serial measurements is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bile Acids and SaltsLiver NeoplasmsCarcinoma, HepatocellularHumansCase-Control StudiesMaleMiddle AgedFemaleProspective StudiesAgedOdds RatioLogistic ModelsRisk FactorsAdultUnited StatesCholangiocarcinoma

Substanzen

Bile Acids and Salts

Autor:innen und Institutionen

  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States.
  • Slone Epidemiology Center, Boston University, Boston, MA, United States.
  • School of Nursing, Yale University, New Haven, CT, United States.
  • Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States.

ORCID-Profile: Jessica L Petrick, Barry I Graubard, Xuehong Zhang, Matthew J Barnett, Julie E Buring, Yu Chen, A Heather Eliassen, J Michael Gaziano, Jonathan N Hofmann, Wen-Yi Huang, Jae H Kang, Jill Koshiol, Erikka Loftfield, I-Min Lee, Steven C Moore, Lorelei A Mucci, Marian L Neuhouser, Christina C Newton, Julie R Palmer, Mark P Purdue, Lynn Rosenberg, Howard D Sesso, Martha Shrubsole, Matthew Triplette, Caroline Y Um, Kala Visvanathan, Eleanor L Watts, Jean Wactawski-Wende, Walter Willett, Fen Wu, Wei Zheng, Peter T Campbell, Dinesh Barupal, Katherine A McGlynn

Förderung

  • PHS HHS
  • NHLBI NIH HHS
  • NCI NIH HHS
  • Intramural Research Program of the Division of Cancer Epidemiology and Genetics, and contracts from the Division of Cancer Prevention, NCI, NIH, DHHS
  • NIH HHS
  • Canadian Institutes of Health Research Fellowship
  • CARET
  • WHI NIH HHS

Zitieren

APA

Watling, C. Z., Petrick, J. L., Graubard, B. I., Zhang, X., Barnett, M. J., Buring, J. E., Chen, Y., Eliassen, A. H., Gaziano, J. M., Hofmann, J. N., Huang, W. Y., Kang, J. H., Koshiol, J., Loftfield, E., Lee, I. M., Moore, S. C., Mucci, L. A., Neuhouser, M. L., Newton, C. C., …, & McGlynn, K. A. (2025). Pre-diagnostic circulating bile acid concentrations and liver cancer risk: a nested case-control analysis of 12 cohorts. JNCI Cancer Spectrum, 9(5). https://doi.org/10.1093/jncics/pkaf086

Vancouver

Watling CZ, Petrick JL, Graubard BI, Zhang X, Barnett MJ, Buring JE, et al. Pre-diagnostic circulating bile acid concentrations and liver cancer risk: a nested case-control analysis of 12 cohorts. JNCI Cancer Spectrum. 2025;9(5). doi:10.1093/jncics/pkaf086

BibTeX
@article{Watling2025,
  author = {Watling, Cody Z and Petrick, Jessica L and Graubard, Barry I and Zhang, Xuehong and Barnett, Matthew J and Buring, Julie E and Chen, Yu and Eliassen, A Heather and Gaziano, J Michael and Hofmann, Jonathan N and Huang, Wen-Yi and Kang, Jae H and Koshiol, Jill and Loftfield, Erikka and Lee, I-Min and Moore, Steven C and Mucci, Lorelei A and Neuhouser, Marian L and Newton, Christina C and Palmer, Julie R and Purdue, Mark P and Rosenberg, Lynn and Sesso, Howard D and Shrubsole, Martha and Tinker, Lesley and Triplette, Matthew and Um, Caroline Y and Visvanathan, Kala and Watts, Eleanor L and Wactawski-Wende, Jean and Willett, Walter and Wu, Fen and Zheng, Wei and Campbell, Peter T and Barupal, Dinesh and McGlynn, Katherine A},
  title = {Pre-diagnostic circulating bile acid concentrations and liver cancer risk: a nested case-control analysis of 12 cohorts},
  journal = {JNCI Cancer Spectrum},
  year = {2025},
  volume = {9},
  number = {5},
  doi = {10.1093/jncics/pkaf086}
}
Kostenlos starten →